Lund University Hospital

This study is testing if adding a third chemotherapy drug (irinotecan) to the standard two-drug combination improves outcomes for people with operable stomach or gastroesophageal junction cancer. Patients receive four cycles of the three-drug chemo before surgery and four more cy…

This study is testing whether adding the oral chemotherapy drug capecitabine to standard carboplatin-based chemotherapy improves outcomes for patients with early triple negative breast cancer before surgery. The main goal is to see if this combination helps more patients achieve …